Cancel anytime
Kimberly-Clark Corporation (KMB)KMB
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: KMB (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -7.48% | Upturn Advisory Performance 2 | Avg. Invested days: 42 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -7.48% | Avg. Invested days: 42 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 45.48B USD |
Price to earnings Ratio 17.66 | 1Y Target Price 150.36 |
Dividends yield (FY) 3.60% | Basic EPS (TTM) 7.72 |
Volume (30-day avg) 2093409 | Beta 0.41 |
52 Weeks Range 114.53 - 148.32 | Updated Date 11/20/2024 |
Company Size Large-Cap Stock | Market Capitalization 45.48B USD | Price to earnings Ratio 17.66 | 1Y Target Price 150.36 |
Dividends yield (FY) 3.60% | Basic EPS (TTM) 7.72 | Volume (30-day avg) 2093409 | Beta 0.41 |
52 Weeks Range 114.53 - 148.32 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-10-22 | When BeforeMarket |
Estimate 1.71 | Actual 1.83 |
Report Date 2024-10-22 | When BeforeMarket | Estimate 1.71 | Actual 1.83 |
Profitability
Profit Margin 12.97% | Operating Margin (TTM) 15.25% |
Management Effectiveness
Return on Assets (TTM) 11.46% | Return on Equity (TTM) 231% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 17.66 | Forward PE 17.76 |
Enterprise Value 51563942211 | Price to Sales(TTM) 2.26 |
Enterprise Value to Revenue 2.57 | Enterprise Value to EBITDA 12.61 |
Shares Outstanding 333484992 | Shares Floating 332651592 |
Percent Insiders 0.17 | Percent Institutions 79.66 |
Trailing PE 17.66 | Forward PE 17.76 | Enterprise Value 51563942211 | Price to Sales(TTM) 2.26 |
Enterprise Value to Revenue 2.57 | Enterprise Value to EBITDA 12.61 | Shares Outstanding 333484992 | Shares Floating 332651592 |
Percent Insiders 0.17 | Percent Institutions 79.66 |
Analyst Ratings
Rating 3.4 | Target Price 130.69 | Buy 3 |
Strong Buy 4 | Hold 11 | Sell 1 |
Strong Sell 1 |
Rating 3.4 | Target Price 130.69 | Buy 3 | Strong Buy 4 |
Hold 11 | Sell 1 | Strong Sell 1 |
AI Summarization
Kimberly-Clark Corporation: A Comprehensive Overview
Company Profile:
History: Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark commenced as a paper mill and later diversified into personal care products. Today, it's a global leader in hygiene and personal care products, with iconic brands like Kleenex, Huggies, and Kotex.
Core Business Areas:
- Personal Care: This segment encompasses baby and child care products (Huggies, Pull-Ups), feminine care (Kotex, U by Kotex), and adult and elder care (Depend, Poise).
- K-C Professional: This segment serves away-from-home markets with essential products like Scott, Kleenex, WypAll, and KleenGuard.
- Consumer Tissue: This segment produces tissue products for at-home use under brands like Kleenex, Cottonelle, and Scott.
Leadership & Structure:
- Chairman & CEO: Michael Hsu
- President & COO: Russ Torres
- CFO: Maria Henry
- Board of Directors: Comprises 11 members with diverse industry and functional expertise.
Top Products & Market Share:
Top Products:
- Huggies: Leading diaper brand in the US with a 26.5% market share.
- Kleenex: Dominant brand in facial tissues with a 30.6% market share.
- Depends: Leading adult incontinence brand with a 55.2% market share.
- **U by Kotex: ** Leading period and bladder leak brand with a 9.5% market share.
- Scott: Well-known brand in bathroom tissue with a 10.4% market share.
Market Share:
- Global: Holds a significant market share in several categories, including diapers (15.6%), feminine care (12.5%), and adult incontinence (16.5%).
- US: Maintains leading positions in diapers (26.5%), facial tissues (30.6%), and adult incontinence (55.2%).
Performance & Reception:
Huggies and Kleenex consistently rank among the top brands in their respective categories. U by Kotex has gained traction as a leading period and bladder leak brand. However, Scott faces stiff competition from private label brands and rivals like Charmin.
Total Addressable Market:
Kimberly-Clark operates in a vast global market for personal care, hygiene, and essential products. The estimated size of this market is:
- Global: $442.5 billion by 2027 (Statista)
- US: $156.5 billion by 2028 (Statista)
Financial Performance:
Recent Financial Statements:
(Based on 2022 Annual Report)
- Revenue: $19.2 billion
- Net Income: $1.5 billion
- Profit Margin: 7.8%
- EPS: $6.28
Year-over-Year Performance:
- Revenue increased by 4.5% compared to 2021.
- Net income decreased by 8.5% compared to 2021.
- EPS decreased by 7.7% compared to 2021.
Cash Flow & Balance Sheet:
- Strong cash flow generation with $2.5 billion in operating cash flow.
- Solid balance sheet with $5.5 billion in cash and equivalents.
Dividends & Shareholder Returns:
Dividend History:
Kimberly-Clark has a long history of dividend payouts, with a current annual dividend of $1.28 per share. Recent dividend yield is 3.5%, with a payout ratio of 51.5%.
Shareholder Returns:
- 1-year return: -1.1%
- 5-year return: 18.5%
- 10-year return: 50.3%
Growth Trajectory:
Historical Growth:
Revenue has grown at a compound annual growth rate (CAGR) of 2.8% over the past 5 years.
Future Growth Projections:
Kimberly-Clark expects organic sales growth of 1-3% in 2023. Analysts predict moderate growth in the long term, driven by innovation and emerging markets.
Recent Growth Initiatives:
- New product launches: Huggies Special Delivery diapers, Depend Fit-Flex for women.
- Strategic partnerships: Collaboration with The Walt Disney Company for licensing and distribution of character-based baby care products.
Market Dynamics:
Industry Trends:
- Growing demand for premium and sustainable products.
- Increasing focus on health and wellness.
- Evolving consumer preferences towards online shopping.
Kimberly-Clark's Positioning:
- Strong brand portfolio and market leadership.
- Focus on innovation and product differentiation.
- Global presence and extensive distribution network.
Competitors:
Key Competitors:
- Procter & Gamble (PG)
- Unilever (UL)
- Essity (ESSITY)
- Seventh Generation (SGEN)
Market Share Comparison:
- Kimberly-Clark holds higher market shares in diapers and adult incontinence compared to its major competitors.
- In feminine care and tissue, the competition is more intense with Procter & Gamble and Unilever.
Competitive Advantages:
- Strong brand recognition and customer loyalty.
- Extensive research and development capabilities.
- Cost-efficient manufacturing and supply chain.
Disadvantages:
- Limited exposure to emerging markets compared to some competitors.
- Vulnerable to commodity price fluctuations and economic downturns.
Potential Challenges & Opportunities:
Key Challenges:
- Intense competition from major rivals.
- Rising input costs and inflationary pressures.
- Changing consumer preferences and evolving retail landscape.
Potential Opportunities:
- Expanding presence in emerging markets.
- Developing innovative and sustainable products.
- Leveraging digital channels and e-commerce.
- Strategic acquisitions and partnerships.
Recent Acquisitions (2020-2023):
1. Softex Indonesia (2020): Acquired for $1.1 billion to expand presence in Southeast Asia's hygiene market.
2. CMPC Tissue (2021): Acquired for $330 million to strengthen position in Latin America's tissue market.
3. Hichold (2023): Acquired for $120 million to expand presence in the European market for baby and feminine care products.
These acquisitions align with Kimberly-Clark's strategy to expand its global footprint, strengthen its product portfolio, and drive long-term growth.
AI-Based Fundamental Rating:
Rating: 7/10
Justification:
- Strong brand portfolio and market leadership.
- Solid financial performance with consistent dividend payouts.
- Focus on innovation and sustainability.
- Exposure to growing markets and long-term demand trends.
Areas of Improvement:
- Limited exposure to emerging markets.
- Vulnerability to economic downturns and commodity price fluctuations.
Sources & Disclaimers:
- Data sources: Kimberly-Clark Corporation annual and quarterly reports, Statista, company websites.
- Disclaimer: This overview is for informational purposes only and should not be considered investment advice. Investing involves risk, and you should conduct your own due diligence before making investment decisions.
This comprehensive overview provides valuable insights into Kimberly-Clark's business, market position, and future potential. By considering the factors mentioned above, investors can gain a deeper understanding of the company and make informed investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Kimberly-Clark Corporation
Exchange | NYSE | Headquaters | Dallas, TX, United States |
IPO Launch date | 1984-12-17 | Chairman & CEO | Mr. Michael D. Hsu |
Sector | Consumer Defensive | Website | https://www.kimberly-clark.com |
Industry | Household & Personal Products | Full time employees | 41000 |
Headquaters | Dallas, TX, United States | ||
Chairman & CEO | Mr. Michael D. Hsu | ||
Website | https://www.kimberly-clark.com | ||
Website | https://www.kimberly-clark.com | ||
Full time employees | 41000 |
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company's K-C Professional segment offers wipers, tissues, towels, apparel, personal protective equipment, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. It also sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to distributors, manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.